Treatment of acute coronary syndrome with glp-1

Details Treatment of acute coronary syndrome with glp-1 Treatment of acute coronary syndrome with glp-1

A - Human Necessities

61

K

A61K 38/26 (2006.01) A61P 9/10 (2006.01) A61K 38/12 (2006.01)

Patent

CA 2407784

The invention relates to methods for treating a patient suffering from acute coronary syndrome, but who is not suffering from a Q-wave myocardial infarction, comprising administration of a therapeutically effective amount of a GLP-1 molecule. The GLP-1 can be self-administered, and can be administered in one or more doses, as needed, on an intermittent or continuous basis, to optimize metabolism in cardiac tissue and to prevent cardiac damage associated with ischemia.

L'invention concerne des procédés servant au traitement d'un patient qui souffre du syndrome coronarien aigu mais pas d'un infarctus du myocarde à onde Q, et comprenant l'administration d'une quantité thérapeutiquement efficace d'une molécule GLP-1. La molécule GLP-1 peut être auto-administrée et peut être administrée en une ou plusieurs doses, selon les besoins, sur une base intermittente ou continue, afin d'optimiser le métabolisme dans le tissu cardiaque et d'empêcher les dommages cardiaques associés à l'ischémie.

Affiliated with

Also associated with

Rating

Treatment of acute coronary syndrome with glp-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of acute coronary syndrome with glp-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of acute coronary syndrome with glp-1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1833789